GNH USA

Europe — EMA

Oxbryta (Voxelotor)

Voxelotor, the active ingredient in Oxbryta, is a hemoglobin oxygen‑binding modulator presented as a tablet for oral use. It is indicated for the treatment of sickle cell disease in adults and pediatric patients aged 12…

Request sourcing

1
Pack/s

What is Voxelotor?

Voxelotor, the active ingredient in Oxbryta, is a hemoglobin oxygen‑binding modulator presented as a tablet for oral use. It is indicated for the treatment of sickle cell disease in adults and pediatric patients aged 12 years and older. GNH USA supplies Oxbryta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxbryta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Voxelotor used for?

Oxbryta is used in the management of sickle cell disease, a genetic disorder affecting hemoglobin.

- Sickle cell disease: Improves hemoglobin levels and reduces hemolysis. - Sickle cell-related vaso‑occlusive crises: May lower the frequency of painful episodes. - Chronic anemia in sickle cell disease: Contributes to better oxygen transport and quality of life.

What are the side effects of Voxelotor?

Adverse reactions reported with Oxbryta are generally mild to moderate.

Common Side Effects: - Headache - Diarrhea - Nausea - Fatigue - Abdominal pain - Dizziness

Serious or Rare Side Effects: - Liver enzyme elevation (ALT/AST) - Severe allergic reactions (anaphylaxis) - Hemolytic crisis - Thromboembolic events - Acute chest syndrome - Severe rash or Stevens‑Johnson syndrome

What precautions apply to Voxelotor?

Before using Oxbryta, consider the following safety measures:

- Monitor   :  Regular    ​      ​                                                                                                                                                                                                                            ​ - Contra‑indication :  Not  recommended  for  patients  with  severe  liver  impairment. - Pregnancy  :  Use only if  the  potential  benefit  outweigh  the  risk  to  the  fetus. - Breastfeeding :  Caution  due  to  potential  exposure  through  milk  but  data  limited. - Drug interaction  :  Review  all  concomitant medications  for potential  pharmacokinetic  interactions. - Store at below 25°C: keep  the  tablet  in  the  original  pack  and  protect  from  moisture.

What does Voxelotor interact with?

A             ... ... ... ...   a  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Voxelotor
Route
Oral Use
Manufacturer
Pfizer Europe Ma Eeig
Origin
EU

Related products